Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

MATERNUS-Kliniken- stock

MAK.DE
DE0006044001
604400

Price

1.40
Today +/-
-0.09
Today %
-6.23 %

MATERNUS-Kliniken- stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the MATERNUS-Kliniken- stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the MATERNUS-Kliniken- stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the MATERNUS-Kliniken- stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze MATERNUS-Kliniken-'s market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

MATERNUS-Kliniken- Stock Price History

DateMATERNUS-Kliniken- Price
12/19/20241.40 undefined
12/18/20241.49 undefined
12/17/20241.53 undefined
12/16/20241.53 undefined
12/13/20241.53 undefined
12/12/20241.53 undefined
12/11/20241.53 undefined
12/10/20241.53 undefined
12/9/20241.52 undefined
12/6/20241.53 undefined
12/5/20241.60 undefined
12/4/20241.60 undefined
12/3/20241.60 undefined
12/2/20241.60 undefined
11/29/20241.59 undefined
11/28/20241.60 undefined
11/27/20241.60 undefined
11/26/20241.60 undefined
11/25/20241.60 undefined
11/22/20241.60 undefined
11/21/20241.60 undefined
11/20/20241.59 undefined

MATERNUS-Kliniken- Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into MATERNUS-Kliniken-, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by MATERNUS-Kliniken- from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects MATERNUS-Kliniken-’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of MATERNUS-Kliniken-. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into MATERNUS-Kliniken-’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing MATERNUS-Kliniken-’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on MATERNUS-Kliniken-’s growth potential.

MATERNUS-Kliniken- Revenue, EBIT and net profit per share

DateMATERNUS-Kliniken- RevenueMATERNUS-Kliniken- EBITMATERNUS-Kliniken- Net Income
2023102.31 M undefined-5.29 M undefined-14.26 M undefined
2022106.7 M undefined-9.35 M undefined-14.08 M undefined
2021111.44 M undefined5.06 M undefined-2.49 M undefined
2020114.3 M undefined1.55 M undefined-9.62 M undefined
2019124.43 M undefined-2.76 M undefined-10.26 M undefined
2018124.28 M undefined2.86 M undefined-1.58 M undefined
2017127.14 M undefined6.24 M undefined-1.46 M undefined
2016124.04 M undefined5.79 M undefined1.1 M undefined
2015123.27 M undefined8.09 M undefined2.36 M undefined
2014122.04 M undefined32.26 M undefined26.84 M undefined
2013113.6 M undefined-3.9 M undefined-12.7 M undefined
2012113.9 M undefined1.3 M undefined-8.6 M undefined
2011110.9 M undefined5.1 M undefined-1.9 M undefined
2010111.8 M undefined7.7 M undefined2 M undefined
2009112.8 M undefined7 M undefined900,000 undefined
2008109.8 M undefined5.4 M undefined-2.7 M undefined
2007106.4 M undefined4.1 M undefined-4.3 M undefined
2006103.3 M undefined-24 M undefined-31.1 M undefined
2005102.1 M undefined21.2 M undefined9.9 M undefined
200499.3 M undefined1.2 M undefined-6.2 M undefined

MATERNUS-Kliniken- Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
36679610310510599102103106109112111110113113122123124127124124114111106102
-86.1143.287.291.94--5.713.030.982.912.832.75-0.89-0.902.73-7.960.820.812.42-2.36--8.06-2.63-4.50-3.77
77.7883.5883.3381.5581.9081.9081.8281.3780.5880.1980.7381.2581.9882.7384.9682.3081.1582.9383.0682.6882.2682.2685.0987.3981.1385.29
285680848686818383858891919196939910210310510210297978687
10-40-5-4-32-69-31-4-202-1-8-122621-1-1-10-9-2-14-14
--140.00---20.00700.00-81.25-250.00-444.44-87.10-50.00---150.00700.0050.00-316.67-92.31-50.00-200.00-900.00-10.00-77.78600.00-
10.810.811.111.111.111.111.119.5212121212121212120.9720.9720.9720.9720.9720.9720.9720.9720.9720.97
--------------------------
Details

Keystats

ⓘ

Revenue and Growth

The MATERNUS-Kliniken- Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the MATERNUS-Kliniken- is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                   
95.23.43.12.73.21.86.25.52.81.81.50.60.51.72.74.624.946.77.553.812.9213.8516.619.537.2
12.545.855.73.950.8444.712.512.412.457.87.97.966.897.146.135.585.685.374.554.99.34
00000000.51.50.30.10.20.133.60.60.611.41.863.53.110.621.110.831.86.17
400300400400400500400400400400400400400400400400389432434437507449444598586586
3.31.59.61.33.356.78.30.50.60.50.60.80.81.11.50.80.961.050.990.040.060.090.050.090.070.25
25.21119.29.812.164.361.311.6128.715.415.314.3101512.414.5314.7217.1217.6613.079.7620.8222.6916.8923.54
179.4181.4172.4169.4165.781.380.2154.838.187.499.696.498.29995.690.886.3183.6779.7277.06101.1139.68143.57128.45121.27116.43
0.80.92.52.42.30.40.70.40.10.10.10.10.10.10.10.10.050.050.380.420.420.420.380.380.380.38
000000000000000000000000.833.180
1.11.81.71.20.60.20.10.1013.313.213.30.21.421.50.990.620.220.130.10.280.220.160.10.03
21.421.717.316.414.113.212.313.213.200013.213.213.213.213.2113.2113.2113.2113.2113.2113.2113.2113.2113.21
0.20.70.50.40.60.104.688.7213.93.75.25.75.73.800.050.35002.090.430.531.550.78
202.9206.5194.4189.8183.395.293.3173.1140.1121.8116.8113.5116.9119.4116.6109.4100.5697.6193.8890.82114.84155.68157.81143.56139.69130.84
228.1217.5213.6199.6195.4159.5154.6184.7152.1130.5132.2128.8131.2129.4131.6121.8115.09112.32111108.48127.9165.44178.63166.24156.58154.38
                                                   
27.62727.727.727.727.727.748.451.951.951.951.951.951.951.951.951.9451.9451.9451.9451.9451.9451.9451.9451.9451.94
0000000000000000003.773.773.773.773.773.773.773.77
26.121.916.211.36.6-25.4-30.2-23.8-54.9-61.1-63.9-63-61.3-63.2-77-84.2-57.72-55.35-58.05-59.52-61.13-71.54-81.11-83.55-95-109.46
00000001.40000000000000007.775.520
000000000000005.400000000000
53.748.943.93934.32.3-2.526-3-9.2-12-11.1-9.4-11.3-19.7-32.3-5.78-3.41-2.35-3.82-5.43-15.84-25.41-20.08-33.78-53.76
2.350.152.248.47.6963.61.61.82.12.844.93.35.35.76.47.26.216.374.634.364.794.644.835.26
00000000000000000001.891.90002.122.12
12.44.34.65.74955.18.416.213.61718.815.31215.714.412.713.1711.1111.978.76.3228.3430.6435.2542.9863.59
000000018.720.725.720.2203.33.3611.615.998.2711.0913.3915.0600000
145.79997.1759.810.29.97.81.331.721.223.13.53.8547.434.353.383.642.182.7551.777.367.386.416.47
160.4153.4153.961.1116.474.381.944.337.476.56362.423.726.130.777.469.9129.9632.9132.5330.6684.4742.7947.2756.3377.44
00083.42769.460.387.332.717.150.945.980.576.677.231.140.7376.6673.873.2297.7390.06129.8116.27111.4105.88
00000001.52.23.63.73.63.63.8448.14101.760.460000.330.37
7.59.510.711.112.811.912.425.782.842.526.627.932.934.339.341.69.478.116.644.84.496.7531.4429.7224.6324.45
7.59.510.794.539.881.372.7114.5117.763.281.277.4117114.7120.576.758.3485.7780.4479.77102.6796.81161.25145.99136.37130.7
167.9162.9164.6155.6156.2155.6154.6158.8155.1139.7144.2139.8140.7140.8151.2154.1128.25115.73113.35112.3133.33181.28204.03193.26192.7208.14
221.6211.8208.5194.6190.5157.9152.1184.8152.1130.5132.2128.7131.3129.5131.5121.8122.47112.32111108.48127.91165.44178.63173.18158.92154.38
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of MATERNUS-Kliniken- provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand MATERNUS-Kliniken-'s financial health and stability.

Assets

MATERNUS-Kliniken-'s assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that MATERNUS-Kliniken- must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of MATERNUS-Kliniken- after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into MATERNUS-Kliniken-'s financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
11-50-5-4-34-616-2502573-4-827200-2-12-7-1-12
11766736563345401555545511111111
0000000000000000000000000
1-20110-2-25-8-1-13-7-50337-847718111
-240-1000100-2000002-29-2-1-3-4-1664
0000000665555544413557765
0000000000000000000000000
0-143420-301-53154311-27961612174
-1-11-4-2-2-1-2-2-100-1-1-3-200-200000-1-2
-38-9-45-100-2-1-10-1-1-3-200-200000-1-2
-36208022000000000000000000
0000000000000000000000000
41-10-9-3-20-8-7-57-1-1-2-1-2-17-1-3-3-84-6-6
0000000120000000000000000
39-1-1-9-3-2070-57-1-1-2-1-2-66-5-8-9-16-2-12-12
-10-200001540000000-4-1-3-5-5-7-7-5-5
0000000000000000000000000
1-12-1000-12-1-410-10004110-3-192-10
-1.57-12.69-0.011.212.541.13-3.27-5.59-1.020.89-5.581.65-0.052.321.72.4810.62-5.167.098.535.2915.0711.4315.322.33
0000000000000000000000000

MATERNUS-Kliniken- stock margins

The MATERNUS-Kliniken- margin analysis displays the gross margin, EBIT margin, as well as the profit margin of MATERNUS-Kliniken-. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for MATERNUS-Kliniken-.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the MATERNUS-Kliniken-'s sales revenue. A higher gross margin percentage indicates that the MATERNUS-Kliniken- retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the MATERNUS-Kliniken-'s earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the MATERNUS-Kliniken-'s total revenue generated. When comparing the revenue margin year over year, investors can gauge the MATERNUS-Kliniken-'s growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the MATERNUS-Kliniken-. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the MATERNUS-Kliniken-'s financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

MATERNUS-Kliniken- Margin History

MATERNUS-Kliniken- Gross marginMATERNUS-Kliniken- Profit marginMATERNUS-Kliniken- EBIT marginMATERNUS-Kliniken- Profit margin
202385.47 %-5.17 %-13.94 %
202281.52 %-8.76 %-13.19 %
202187.51 %4.54 %-2.23 %
202085.48 %1.36 %-8.42 %
201982.67 %-2.22 %-8.24 %
201882.76 %2.3 %-1.27 %
201782.88 %4.9 %-1.15 %
201683.06 %4.67 %0.89 %
201583.16 %6.56 %1.91 %
201481.91 %26.43 %22 %
201382.04 %-3.43 %-11.18 %
201284.37 %1.14 %-7.55 %
201182.24 %4.6 %-1.71 %
201081.75 %6.89 %1.79 %
200981.03 %6.21 %0.8 %
200880.15 %4.92 %-2.46 %
200780.55 %3.85 %-4.04 %
200681.03 %-23.23 %-30.11 %
200581.39 %20.76 %9.7 %
200482.07 %1.21 %-6.24 %

MATERNUS-Kliniken- Stock Sales Revenue, EBIT, Earnings per Share

The MATERNUS-Kliniken- earnings per share therefore indicates how much revenue MATERNUS-Kliniken- has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue MATERNUS-Kliniken- earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates MATERNUS-Kliniken-'s earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of MATERNUS-Kliniken-’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating MATERNUS-Kliniken-'s prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

MATERNUS-Kliniken- Revenue, EBIT and net profit per share

DateMATERNUS-Kliniken- Sales per ShareMATERNUS-Kliniken- EBIT per shareMATERNUS-Kliniken- Earnings per Share
20234.88 undefined-0.25 undefined-0.68 undefined
20225.09 undefined-0.45 undefined-0.67 undefined
20215.31 undefined0.24 undefined-0.12 undefined
20205.45 undefined0.07 undefined-0.46 undefined
20195.93 undefined-0.13 undefined-0.49 undefined
20185.93 undefined0.14 undefined-0.08 undefined
20176.06 undefined0.3 undefined-0.07 undefined
20165.92 undefined0.28 undefined0.05 undefined
20155.88 undefined0.39 undefined0.11 undefined
20145.82 undefined1.54 undefined1.28 undefined
20135.41 undefined-0.19 undefined-0.6 undefined
20125.42 undefined0.06 undefined-0.41 undefined
20115.28 undefined0.24 undefined-0.09 undefined
20105.32 undefined0.37 undefined0.1 undefined
20095.37 undefined0.33 undefined0.04 undefined
20085.23 undefined0.26 undefined-0.13 undefined
20075.07 undefined0.2 undefined-0.2 undefined
20064.92 undefined-1.14 undefined-1.48 undefined
20055.24 undefined1.09 undefined0.51 undefined
20048.95 undefined0.11 undefined-0.56 undefined

MATERNUS-Kliniken- business model

Maternus Kliniken AG is a leading company in the German healthcare industry. The company has a history dating back to 1908 when the foundation for the first clinic was laid. Since then, the company has developed into a diverse corporation with various divisions and offerings. The business model of Maternus Kliniken AG is focused on providing people with high-quality and effective medical services. The company emphasizes holistic treatment of diseases and injuries. The company philosophy of Maternus Kliniken AG is that health is a valuable asset that needs to be nurtured, protected, and preserved. The company now operates several clinics throughout the country, specializing in different medical activities. One of the most well-known divisions of Maternus Kliniken AG is the geriatric clinics, which specialize in treating older people. Here, patients are treated for conditions such as spasms, dizziness, falls, or other age-related ailments that require professional help. In addition to geriatric clinics, Maternus Kliniken AG also operates clinics for cardiology, orthopedics, and neurology. Here, diseases of the heart, bones, and nervous system are treated. Furthermore, the company has a psychiatry department. Another focus of Maternus Kliniken AG is outpatient services. Services such as physiotherapy, occupational therapy, and speech therapy are offered. The company also provides rehabilitation measures for patients who require rehabilitation following treatment or surgery. However, Maternus Kliniken AG is not only specialized in medical treatments. For several years now, the company has also offered a wide range of wellness programs. Here, patients can spend a relaxing time, recover, and recharge their energy. The wellness offering includes services such as massages, yoga classes, fitness programs, as well as weight loss programs. Overall, it can be said that Maternus Kliniken AG is a very diverse company that caters to many different needs of patients. The company philosophy, emphasis on holistic treatment, and wide range of offerings make it an important player in the German healthcare sector. MATERNUS-Kliniken- is one of the most popular companies on Eulerpool.com.

MATERNUS-Kliniken- SWOT Analysis

Strengths

Maternus Kliniken AG possesses several strengths that contribute to its success in the market. These strengths include:

  • Strong brand reputation and recognition
  • Wide range of specialized healthcare services
  • State-of-the-art medical facilities and equipment
  • Experienced and highly skilled medical professionals
  • Strong financial position and stability

Weaknesses

Despite its strengths, Maternus Kliniken AG also faces certain weaknesses that may hinder its overall performance and growth. These weaknesses include:

  • Reliance on a limited geographic presence, which limits market reach
  • Potential for high costs associated with maintaining modern medical equipment
  • Dependency on third-party insurance providers for revenue
  • Lack of diversification in service offerings
  • Issues with internal communication and coordination between departments

Opportunities

Maternus Kliniken AG has several opportunities to capitalize on in the market. These opportunities include:

  • Expansion into new geographic regions to reach a broader customer base
  • Growing demand for specialized healthcare services
  • Collaborations with other healthcare providers to offer comprehensive solutions
  • Investment in research and development to stay at the forefront of medical advancements
  • Introduction of innovative service offerings to attract more patients

Threats

Maternus Kliniken AG faces certain threats in the competitive market. These threats include:

  • Increase in competition from other healthcare providers
  • Regulatory changes impacting reimbursement rates and healthcare policies
  • Economic downturns affecting patients' ability to afford healthcare services
  • Technological advancements leading to potential disruption in traditional healthcare models
  • Negative publicity or reputation damage impacting patient trust and loyalty
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

MATERNUS-Kliniken- Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

MATERNUS-Kliniken- historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

MATERNUS-Kliniken- shares outstanding

The number of shares was MATERNUS-Kliniken- in 2023 — This indicates how many shares 20.97 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue MATERNUS-Kliniken- earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates MATERNUS-Kliniken-'s earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of MATERNUS-Kliniken-’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating MATERNUS-Kliniken-'s prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

MATERNUS-Kliniken- stock splits

In MATERNUS-Kliniken-'s history, there have been no stock splits.
MATERNUS-Kliniken- does not pay out any dividends.
MATERNUS-Kliniken- does not pay out any dividends.
MATERNUS-Kliniken- does not pay out any dividends.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for MATERNUS-Kliniken-.

MATERNUS-Kliniken- shareholders

%
Name
Stocks
Change
Date
81.69876 % Wohlers de Meie (Sylvia)17,132,23006/5/2024
1

MATERNUS-Kliniken- Executives and Management Board

Dr. Daniela Rossa-heise

MATERNUS-Kliniken- Chairwoman of the Supervisory Board (since 2017)
Compensation 10,000

Mr. Sven Olschar

MATERNUS-Kliniken- Deputy Chairman of the Supervisory Board, Employee Representative (since 2008)
Compensation 7,500

Mr. Joerg Arnold

MATERNUS-Kliniken- Member of the Supervisory Board, Employee Representative
Compensation 5,000

Mr. Karl Ehlerding

(81)
MATERNUS-Kliniken- Member of the Supervisory Board
Compensation 5,000

Mr. Dietmar Erdmeier

MATERNUS-Kliniken- Member of the Supervisory Board, Employee Representative
Compensation 5,000
1
2
3

Most common questions regarding MATERNUS-Kliniken-

What values and corporate philosophy does MATERNUS-Kliniken- represent?

Maternus Kliniken AG represents values and a corporate philosophy centered around providing high-quality healthcare services. They prioritize patient care, constantly striving to deliver the best medical treatments and personalized care in their state-of-the-art facilities. Maternus Kliniken AG values compassion, professionalism, and patient-centric care, placing individuals at the heart of their operations. With a commitment to continuous improvement, they aim to maintain their position as a leader in the healthcare industry. Maternus Kliniken AG's strong corporate philosophy focuses on delivering excellence in healthcare and ensuring the well-being and satisfaction of their patients.

In which countries and regions is MATERNUS-Kliniken- primarily present?

Maternus Kliniken AG is primarily present in Germany.

What significant milestones has the company MATERNUS-Kliniken- achieved?

Maternus Kliniken AG, a leading healthcare provider, has achieved remarkable milestones over the years. The company has successfully expanded its network of specialized clinics and medical centers, offering exceptional healthcare services to patients. Maternus Kliniken AG has consistently prioritized patient care, gaining recognition for its commitment to excellent medical treatments and services. The company has also fostered strategic partnerships, enhancing collaboration with industry experts, medical professionals, and renowned institutions. Maternus Kliniken AG's dedication to innovation and continuous improvement has resulted in improved patient outcomes and increased trust among investors and stakeholders. As a reputable healthcare provider, Maternus Kliniken AG continues to strive towards achieving new milestones in the industry.

What is the history and background of the company MATERNUS-Kliniken-?

Maternus Kliniken AG is a renowned healthcare company specializing in the operation of hospitals and rehabilitation clinics in Germany. Founded in 1982, Maternus Kliniken AG has a rich history of providing high-quality medical services and care to patients. With a strong focus on patient outcomes and well-being, the company has built a reputation for excellence in the healthcare industry. Maternus Kliniken AG continuously strives to improve its services, invest in advanced medical technology, and expand its network of healthcare facilities to meet the growing demand for top-notch medical care in Germany.

Who are the main competitors of MATERNUS-Kliniken- in the market?

The main competitors of Maternus Kliniken AG in the market include other prominent healthcare providers and hospital chains. These competitors may include companies like Asklepios Kliniken AG, Rhoen-Klinikum AG, and Sana Kliniken AG. These healthcare organizations operate in the same market and offer similar services, creating a competitive environment for Maternus Kliniken AG.

In which industries is MATERNUS-Kliniken- primarily active?

Maternus Kliniken AG is primarily active in the healthcare industry.

What is the business model of MATERNUS-Kliniken-?

The business model of Maternus Kliniken AG is focused on providing healthcare services through its network of hospitals and clinics. The company operates in the field of acute and rehabilitative care, specializing in orthopedics, neurology, cardiology, and psychosomatic medicine. Maternus Kliniken AG aims to offer high-quality medical treatment, customized care plans, and advanced medical technologies to ensure the well-being and recovery of its patients. With a patient-centric approach, Maternus Kliniken AG strives to be a leading healthcare provider, delivering comprehensive and specialized services to improve the lives of individuals in need of medical care.

What is the P/E ratio of MATERNUS-Kliniken- 2024?

The P/E ratio cannot be calculated for MATERNUS-Kliniken- at the moment.

What is the P/S ratio of MATERNUS-Kliniken- 2024?

The P/S cannot be calculated for MATERNUS-Kliniken- currently.

What is the Quality Investing of MATERNUS-Kliniken-?

The Quality Investing for MATERNUS-Kliniken- is 3/10.

What is the revenue of MATERNUS-Kliniken- 2024?

The revenue cannot currently be calculated for MATERNUS-Kliniken-.

How high is the profit of MATERNUS-Kliniken- 2024?

The profit cannot currently be calculated for MATERNUS-Kliniken-.

What is the business model of MATERNUS-Kliniken-

The Maternus Kliniken AG is a leading company in the healthcare industry and offers a wide range of medical services. The company operates in several sectors, including rehabilitation, elderly care, and outpatient care. Maternus' rehabilitation clinics focus on the treatment of musculoskeletal disorders, neurological disorders, cardiovascular diseases, and addiction disorders. The company operates eleven rehabilitation clinics in Germany and offers both inpatient and outpatient rehabilitation treatments. Maternus also operates elderly care facilities that provide comprehensive care and support for older people. The facilities are tailored to the needs of older individuals and offer a familial atmosphere where residents feel comfortable and safe. The care offerings range from assisted living and nursing home placements to mobile nursing services. Maternus' outpatient care offers a wide range of services tailored to the individual needs of customers. The services include basic care, medical care, household support, and caregiving. In addition to medical services, Maternus also offers various products that can be used for rehabilitation and care. These include various aids such as wheelchairs, walkers, hospital beds, and care clothing. The business model of Maternus Kliniken AG is based on the vision of promoting health and well-being for all and providing comprehensive medical care at the highest level. The company aims to continuously improve and expand its services to meet the needs of its customers. With a dedicated and competent workforce and state-of-the-art medical equipment, Maternus ensures high-quality medical care for all patients. Maternus Kliniken AG is prepared for the legal and economic changes in the healthcare sector and responds quickly and flexibly to market changes. The company places great emphasis on efficient and cost-effective processes in order to offer high-quality services at competitive prices. Overall, Maternus Kliniken AG offers a wide range of medical services and products tailored to the individual needs of customers. With a focus on quality and innovation, the company strives to meet the needs of its customers and provide comprehensive medical care at the highest level.

What is the MATERNUS-Kliniken- dividend?

MATERNUS-Kliniken- pays a dividend of 0 EUR distributed over payouts per year.

How often does MATERNUS-Kliniken- pay dividends?

The dividend cannot currently be calculated for MATERNUS-Kliniken- or the company does not pay out a dividend.

What is the MATERNUS-Kliniken- ISIN?

The ISIN of MATERNUS-Kliniken- is DE0006044001.

What is the MATERNUS-Kliniken- WKN?

The WKN of MATERNUS-Kliniken- is 604400.

What is the MATERNUS-Kliniken- ticker?

The ticker of MATERNUS-Kliniken- is MAK.DE.

How much dividend does MATERNUS-Kliniken- pay?

Over the past 12 months, MATERNUS-Kliniken- paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MATERNUS-Kliniken- is expected to pay a dividend of 0 EUR.

What is the dividend yield of MATERNUS-Kliniken-?

The current dividend yield of MATERNUS-Kliniken- is .

When does MATERNUS-Kliniken- pay dividends?

MATERNUS-Kliniken- pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of MATERNUS-Kliniken-?

MATERNUS-Kliniken- paid dividends every year for the past 0 years.

What is the dividend of MATERNUS-Kliniken-?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is MATERNUS-Kliniken- located?

MATERNUS-Kliniken- is assigned to the 'Health' sector.

Wann musste ich die Aktien von MATERNUS-Kliniken- kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of MATERNUS-Kliniken- from 8/31/2000 amounting to 0.38 EUR, you needed to have the stock in your portfolio before the ex-date on 8/31/2000.

When did MATERNUS-Kliniken- pay the last dividend?

The last dividend was paid out on 8/31/2000.

What was the dividend of MATERNUS-Kliniken- in the year 2023?

In the year 2023, MATERNUS-Kliniken- distributed 0 EUR as dividends.

In which currency does MATERNUS-Kliniken- pay out the dividend?

The dividends of MATERNUS-Kliniken- are distributed in EUR.

All fundamentals about MATERNUS-Kliniken-

Our stock analysis for MATERNUS-Kliniken- Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MATERNUS-Kliniken- Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.